Skip to main content
. 2016 May 23;34(20):2350–2358. doi: 10.1200/JCO.2015.62.6630

Fig 1.

Fig 1.

CONSORT diagram. AC, doxorubicin plus cyclophosphamide; AC→P, doxorubicin plus cyclophosphamide followed by paclitaxel; ER, estrogen receptor; GHI, Genomic Health, Inc.; IBC, invasive breast cancer; NSABP, National Surgical Adjuvant Breast and Bowel Project; qPCR, quantitative polymerase chain reaction; RT-PCR, reverse transcriptase polymerase chain reaction; RTX, radiotherapy; TAM, tamoxifen.